10/13/2018

Radio Interview: Dr. Amy Shapiro discusses HEMLIBRA

Indiana Hemophilia & Thrombosis Center's Dr. Amy Shapiro discussed the new novel therapy, HEMLIBRA, with the hosts of Caregiver Crossing,...

Read more

10/10/2018

FOX59 Video: FDA approves new bleeding disorder drug

Changing the life of an Indiana two-year-old with the approved use of a new drug. Two-year-old Griffin Picket was enduring...

Read more

10/04/2018

HEMLIBRA® now option for those with, without inhibitor (Hemophilia A)

On October 4, 2018, the FDA approved HEMLIBRA ® for prevention (prophylaxis) of bleeding episodes in adults and children ages...

Read more

09/27/2018

New agent joins hydroxyurea as FDA-approved sickle cell treatment

By Dana LeBlanc, M.D., and Emily Riehm Meier, M.D., M.S.H.S., FAAP Sickle cell disease (SCD) affects 70,000-100,000 Americans and...

Read more

11/15/2017

Amish Mutation Protects Against Diabetes and May Extend Life

By Anahad O'Connor Amish people living in a rural part of Indiana have a rare genetic mutation that protects...

Read more

First ... 11 12 13 14 15  

Contact IHTC

8326 Naab Road
Indianapolis, IN 46260

317.871.0000
877.CLOTTER (877.256.8837)
317.871.0010 (fax)